US 9770452
Quinoxaline derivatives as GPR6 modulators
granted A61KA61K31/197A61K31/498
Quick answer
US patent 9770452 (Quinoxaline derivatives as GPR6 modulators) held by Takeda Pharmaceutical Company Limited expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Sep 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/197, A61K31/498, A61K31/4985, A61K31/5025